Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 3 | 2018 | 344 | 1.350 |
Why?
|
| Liver Diseases | 3 | 2021 | 238 | 1.330 |
Why?
|
| End Stage Liver Disease | 3 | 2016 | 61 | 1.200 |
Why?
|
| Biliary Atresia | 4 | 2022 | 22 | 1.180 |
Why?
|
| Liver Transplantation | 6 | 2021 | 1268 | 1.090 |
Why?
|
| Gastroenterology | 2 | 2018 | 134 | 1.070 |
Why?
|
| Liver | 7 | 2022 | 1230 | 0.970 |
Why?
|
| Hepatitis | 3 | 2020 | 35 | 0.960 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 59 | 0.840 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2021 | 29 | 0.790 |
Why?
|
| Hyperammonemia | 2 | 2020 | 10 | 0.780 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2018 | 52 | 0.760 |
Why?
|
| Congenital Hyperinsulinism | 1 | 2020 | 13 | 0.750 |
Why?
|
| Child | 13 | 2021 | 6927 | 0.730 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2019 | 11 | 0.710 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 185 | 0.700 |
Why?
|
| Penicillamine | 1 | 2018 | 12 | 0.680 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2018 | 19 | 0.670 |
Why?
|
| Liver Cirrhosis | 2 | 2022 | 297 | 0.670 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2018 | 19 | 0.670 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 12 | 0.670 |
Why?
|
| Chelating Agents | 1 | 2018 | 69 | 0.650 |
Why?
|
| Zinc | 1 | 2018 | 91 | 0.650 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 222 | 0.640 |
Why?
|
| Cholestasis | 3 | 2016 | 47 | 0.610 |
Why?
|
| Portal System | 1 | 2015 | 13 | 0.530 |
Why?
|
| Peptic Ulcer | 1 | 2015 | 19 | 0.520 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2015 | 19 | 0.510 |
Why?
|
| Growth Disorders | 1 | 2015 | 63 | 0.510 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 34 | 0.510 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 1565 | 0.510 |
Why?
|
| Physician's Role | 1 | 2016 | 179 | 0.510 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 35 | 0.510 |
Why?
|
| Portal Vein | 1 | 2015 | 120 | 0.500 |
Why?
|
| Infant, Newborn | 6 | 2020 | 2380 | 0.400 |
Why?
|
| Humans | 32 | 2022 | 86644 | 0.400 |
Why?
|
| Biopsy | 3 | 2020 | 1163 | 0.360 |
Why?
|
| Infant | 8 | 2022 | 3047 | 0.350 |
Why?
|
| Pediatricians | 2 | 2018 | 17 | 0.310 |
Why?
|
| Pancreatitis, Chronic | 2 | 2021 | 49 | 0.310 |
Why?
|
| Adolescent | 9 | 2018 | 8981 | 0.290 |
Why?
|
| Portoenterostomy, Hepatic | 2 | 2022 | 3 | 0.280 |
Why?
|
| Meperidine | 1 | 2005 | 13 | 0.280 |
Why?
|
| Hypervitaminosis A | 1 | 2005 | 2 | 0.270 |
Why?
|
| Midazolam | 1 | 2005 | 48 | 0.270 |
Why?
|
| Vitamin A | 1 | 2005 | 27 | 0.270 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 235 | 0.260 |
Why?
|
| Dietary Supplements | 1 | 2005 | 128 | 0.250 |
Why?
|
| Hypnotics and Sedatives | 1 | 2005 | 125 | 0.250 |
Why?
|
| Fibrosis | 3 | 2022 | 203 | 0.240 |
Why?
|
| Endoscopy | 2 | 2018 | 332 | 0.200 |
Why?
|
| Nutritional Status | 2 | 2018 | 83 | 0.190 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 977 | 0.190 |
Why?
|
| Fatal Outcome | 1 | 2021 | 293 | 0.190 |
Why?
|
| Esophageal Atresia | 1 | 2019 | 13 | 0.180 |
Why?
|
| Child, Preschool | 4 | 2018 | 3612 | 0.170 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2018 | 23 | 0.170 |
Why?
|
| Female | 10 | 2021 | 44533 | 0.160 |
Why?
|
| Copper | 1 | 2018 | 71 | 0.160 |
Why?
|
| Pancreas | 1 | 2019 | 239 | 0.160 |
Why?
|
| Bile Ducts | 3 | 2010 | 59 | 0.160 |
Why?
|
| Abdominal Pain | 2 | 2021 | 137 | 0.160 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 3640 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2021 | 873 | 0.150 |
Why?
|
| Jaundice | 1 | 2016 | 14 | 0.150 |
Why?
|
| Fructose | 1 | 2016 | 35 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2016 | 38 | 0.140 |
Why?
|
| Male | 12 | 2020 | 40966 | 0.140 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 69 | 0.140 |
Why?
|
| Anticonvulsants | 1 | 2016 | 126 | 0.130 |
Why?
|
| Clarithromycin | 1 | 2015 | 7 | 0.130 |
Why?
|
| Amoxicillin | 1 | 2015 | 13 | 0.130 |
Why?
|
| Metronidazole | 1 | 2015 | 26 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2018 | 971 | 0.130 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 31 | 0.130 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2014 | 9 | 0.120 |
Why?
|
| Hyperbilirubinemia | 1 | 2014 | 20 | 0.120 |
Why?
|
| Choledochal Cyst | 1 | 2014 | 5 | 0.120 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2014 | 17 | 0.120 |
Why?
|
| Failure to Thrive | 1 | 2014 | 17 | 0.120 |
Why?
|
| Peritonitis | 1 | 2014 | 29 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 25 | 0.120 |
Why?
|
| Islam | 1 | 2013 | 34 | 0.120 |
Why?
|
| Lung | 1 | 2019 | 1170 | 0.110 |
Why?
|
| Health Education | 1 | 2013 | 101 | 0.110 |
Why?
|
| Nutritional Support | 1 | 2013 | 17 | 0.110 |
Why?
|
| Nutrition Assessment | 1 | 2013 | 21 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 894 | 0.110 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2013 | 225 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2015 | 371 | 0.100 |
Why?
|
| Nutritional Requirements | 2 | 2013 | 17 | 0.100 |
Why?
|
| Giant Cells | 1 | 2010 | 19 | 0.100 |
Why?
|
| Tissue Donors | 1 | 2013 | 463 | 0.100 |
Why?
|
| Angioplasty | 1 | 2010 | 70 | 0.090 |
Why?
|
| Organ Transplantation | 1 | 2013 | 265 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 360 | 0.090 |
Why?
|
| Tissue and Organ Procurement | 1 | 2013 | 311 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2009 | 7 | 0.090 |
Why?
|
| Methylmalonic Acid | 1 | 2009 | 6 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2601 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 508 | 0.090 |
Why?
|
| Short Bowel Syndrome | 1 | 2009 | 37 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2022 | 8489 | 0.080 |
Why?
|
| Pancreatectomy | 2 | 2021 | 148 | 0.070 |
Why?
|
| Adult | 5 | 2021 | 25648 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 7993 | 0.070 |
Why?
|
| Intestines | 1 | 2009 | 411 | 0.070 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 31 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2005 | 179 | 0.060 |
Why?
|
| Safety | 1 | 2005 | 152 | 0.060 |
Why?
|
| Hematoma | 1 | 2005 | 104 | 0.060 |
Why?
|
| Gestational Age | 1 | 2005 | 311 | 0.060 |
Why?
|
| Respiration | 1 | 2005 | 262 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2005 | 268 | 0.060 |
Why?
|
| Bilirubin | 1 | 2022 | 125 | 0.050 |
Why?
|
| Medical Indigency | 1 | 2002 | 2 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 49 | 0.050 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 331 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2021 | 327 | 0.050 |
Why?
|
| Risk Factors | 2 | 2005 | 5417 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2000 | 478 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 702 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 350 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 376 | 0.040 |
Why?
|
| Cerebral Palsy | 1 | 2016 | 90 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2016 | 118 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2016 | 63 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2016 | 186 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2501 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 27 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2013 | 30 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 38 | 0.030 |
Why?
|
| Micronutrients | 1 | 2013 | 17 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 190 | 0.030 |
Why?
|
| Malnutrition | 1 | 2013 | 34 | 0.030 |
Why?
|
| Perception | 1 | 2013 | 168 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1686 | 0.030 |
Why?
|
| Epilepsy | 1 | 2016 | 397 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2013 | 135 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2013 | 220 | 0.030 |
Why?
|
| Body Weight | 1 | 2013 | 459 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2014 | 695 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 996 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 5976 | 0.020 |
Why?
|
| Alagille Syndrome | 1 | 2010 | 5 | 0.020 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2010 | 12 | 0.020 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2010 | 17 | 0.020 |
Why?
|
| Hypopituitarism | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cholangiography | 1 | 2010 | 41 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2010 | 70 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2010 | 60 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2010 | 119 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2010 | 95 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2010 | 127 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 770 | 0.020 |
Why?
|
| Acidosis | 1 | 2009 | 55 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 746 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1160 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2005 | 1805 | 0.020 |
Why?
|
| Living Donors | 1 | 2010 | 339 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 711 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1621 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1036 | 0.020 |
Why?
|
| Osteopontin | 1 | 2005 | 47 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2005 | 249 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 393 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 1585 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 683 | 0.010 |
Why?
|
| United States | 1 | 2013 | 6672 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 2330 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 669 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1284 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 25028 | 0.010 |
Why?
|
| Ventricular Dysfunction | 1 | 2000 | 28 | 0.010 |
Why?
|
| Radiography | 1 | 2002 | 813 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 2818 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1981 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 446 | 0.010 |
Why?
|
| Prevalence | 1 | 2002 | 1239 | 0.010 |
Why?
|
| Smoking | 1 | 2002 | 609 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 2767 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2002 | 806 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 18415 | 0.000 |
Why?
|